Top

Published in:

01-09-2015 | Original Article

Elevated high-mobility group box1 level is associated with alterations of interferon gamma in Egyptians with lupus nephritis

Authors: Hoiyda A. Abdel Rasol, Wafaa Gaber, Margeret A. Aziz, Abeer Galal El-Din Ahmed Rabie

Published in: Comparative Clinical Pathology | Issue 5/2015

Abstract

High-mobility group box protein-1 (HMGB1) is identified as a pro-inflammatory mediator of tissue injury. Interferon-gamma (IFN-γ) dose dependently induced the release of HMGB1. The understanding of systemic lupus erythematosus (SLE) cytokine networks is very important for SLE treatment strategy and drug development. The purpose of this study is to determine the association of HMGB1 and IFN-γ levels to lupus nephritis and their relation to disease activity, autoantibodies, and certain laboratory parameters. The study population consisted of 50 lupus nephritis patients compared to 30 age- and sex-matched healthy controls (HC). HMGB1 and IFN-γ levels were measured by ELISA method. The plasma levels of HMGB1 and IFN-γ were significantly increased in lupus nephritis patients compared to HC (P < 0.05 and P < 0.01, respectively). Additionally, plasma HMGB1 was positively correlated with IFN-γ (P < 0.001), creatinine (P < 0.05), ESR (P < 0.05), 24-h urinary protein (P < 0.001), and negatively correlated with serum albumin (P < 0.05). HMGB1 and IFN-γ may contribute to the generation of lupus nephritis and may be a potential role for therapies targeting cytokines and HMGB1 in preventing or limiting lupus nephritis in the vulnerable SLE patients.

Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M (2010) HMGB1 in systemic lupus erythematosus: its role in cutaneous lesions development. Autoimmun Rev 9:661–665CrossRefPubMed

Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg C, Bijl M (2011) High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res Ther 13(3):R71PubMedCentralCrossRefPubMed

Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E, Arinobu Y, Yamaoka K, Niiro H, Shinozaki M, Hirakata H, Horiuchi T, Otsuka T, Niho Y (1999) Th1/Th2 balance of T helper cells in systemic lupus erythromatosus. Arthritis Rheum 42:1644–1648CrossRefPubMed

Al-janadi M, Al-Balia S, Al-Dalaan A, Razuddin S (1993) Cytokine profile in systemic lupus erythromatosus, rheumatoid arthritis and other rheumatic diseases. J Clin Immunol 13:58–67CrossRefPubMed

Austin HA III, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH (1983) Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 75:382–391CrossRefPubMed

Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749–795CrossRefPubMed

Bombardier C, Gladman D, Urowitz M, Caron D, Chang C (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed

Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, Stenvinkel P, Tracey KJ (2008) High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD). Mol Med 14(3–4):109–115PubMedCentralPubMed

Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, Glauser MP (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6:164CrossRefPubMed

Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS (2005) TACI and BAFF-R mediate isotype switching in B-cells. J Exp Med 201:35–39PubMedCentralCrossRefPubMed

Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF (2006) A role for BLyS in the activation of innate immune cells. Blood 2006(108):2687–2694CrossRef

Churg J, Sobin LH (1982) Renal disease. In: Churg J, Sobin LH (eds) Classification and atlas of glomerular disease. Igaku-Shoin, Tokyo-New York, pp 127–149

Dawson B, Trapp RG (2001) Basic and clinical biostatistics, 3rd edn. Mcgraw-Hill Inc, New York

Deriy LV, Beno DW, Uhing MR, Jiyamapa-Serna VA, Kimura RE (2002) Splenectomy ablates endotoxin-induced IFN-γ response in rats. Shock 17:312CrossRefPubMed

Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3:955.5CrossRef

Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369CrossRefPubMed

Guha M, Mackman N (2001) LPS induction of gene expression in human monocytes. Cell Signal 13:85CrossRefPubMed

Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, Miyasaka N (2008) Excessive production of IFN-γ in patients B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily 13B. J Immunol 181:2211–2219CrossRefPubMed

Hayashi A, Nagafuchi H, Ito I, Hirota K, Yoshida M, Ozaki S (2009) Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity. Mod Rheumatol 19:283–292CrossRefPubMed

Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725CrossRefPubMed

Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MG, Ly N, Woodward RN, Fry KE, Lau AY, Prentice JG, Wohlgemuth JG et al (2004) Coordinate overexpression of interferon-γ-induced genes in systemic lupus erythematosus. Arthritis Rheum 50:3958–3967CrossRefPubMed

Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H, Ulloa L, Yang H, Yan XJ, Chiorazzi N et al (2002) High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 46:2598CrossRefPubMed

Li J, Xie H, Wen T, Liu H, Zhu W, Chen X (2010) Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol 37:766–775CrossRefPubMed

Ma C, Jiao Y, Zhang J, Yang Q, Zhang Z, Shen Y, Chen Z, Zhao Y (2012) Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int 32:395–402CrossRefPubMed

Mannick J, Schonhoff BC, Papeta N, Ghafourifar P, Szibor M, Fang K, Gaston B (2001) S-Nitrosylation of mitochondrial caspases. J Cell Biol 154:1111PubMedCentralCrossRefPubMed

Qing X, Pitashny M, Thomas DB, Barrat FJ, Hogarth MP, Putterman C (2008) Pathogenic anti- DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett 121:61–73PubMedCentralCrossRefPubMed

Rauvala H, Rouhiainen A (2010) Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim Biophys Acta 1799:164–170CrossRefPubMed

Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H et al (2003) IFN-γ induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 170:3890–3897CrossRefPubMed

Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Müller S, Iannacone M, Traversari C, Bianchi ME, Manfredi AA (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 5:825–830PubMedCentralCrossRefPubMed

Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR (1998) IFN-γ receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 161:494–503PubMed

Uhm W S, Na K, Song G W, Jung S S, Lee T, Park M H. et al (2003) Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford). 42935–938.938

Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M, Voll RE (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 205:3007–3018PubMedCentralCrossRefPubMed

Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164:1768CrossRefPubMed

Wibisono D, Csernok E, Lamprecht P, Holle JU, Gross WL, Moosig F (2010) Serum HMGB1 levels are increased in active Wegener’s granulomatosis and differentiate between active forms of ANCA-associated vasculitis. Ann Rheum Dis 69:1888–1889CrossRefPubMed

Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I (2003) High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 49(9):1535–1537CrossRefPubMed

Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS (2008) High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-{alpha} production in human monocytes. J Immunol 180:5067–5074CrossRefPubMed

Title: Elevated high-mobility group box1 level is associated with alterations of interferon gamma in Egyptians with lupus nephritis
Authors: Hoiyda A. Abdel Rasol
Wafaa Gaber
Margeret A. Aziz
Abeer Galal El-Din Ahmed Rabie
Publication date: 01-09-2015
Publisher: Springer London
Published in: Comparative Clinical Pathology / Issue 5/2015
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI: https://doi.org/10.1007/s00580-014-2018-3

2024 ASCO Annual Meeting

Springer Medicine

Elevated high-mobility group box1 level is associated with alterations of interferon gamma in Egyptians with lupus nephritis

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2015

Scolicidal effect of the aromatic water of Zataria multiflora: an in vitro study

Evaluation the effects of N-acetyl cysteine on pericardial adhesions in experimental rabbit models

Effect of Persian sage (Salvia Rhytidia) extract on histomorphometric changes of cerebellum following ischemia reperfusion injuries in rat

Protective effect of Lithium Chloride against Trimethyltin-induced hippocampal degeneration and comorbid depression in rats

The effect of caraway (Carum carvi L.) on the blood antioxidant enzymes and lipid peroxidation in streptozotocin-induced diabetic rats

A case of chronic lymphoblastic leukemia with an abnormal rare karyotype